Thing 5.02 Separation of Supervisors or Particular Police Officers; Political Election of Supervisors;

          Visit of Particular Police Officers; Compensatory Setups of Particular
          Policemans.

Resignation of present President, Head Of State as well as Principal
Exec Police Officer

On January 12, 2023, Gil Cost, M.D. surrendered as President as well as
Head of state of NeuroBo Pharmaceuticals, Inc., a Delaware company (the
“Business”), efficient instantly. Dr. Cost’s resignation did not arise from a
argument with the Business on any kind of issue associating with the Business’s
procedures, plans or methods.

About Dr. Cost’s separation, on January 16, 2023, the Business as well as Dr. Cost participated in a Splitting up as well as Launch Arrangement (the “Splitting up
Arrangement”).

According to the conditions of the Splitting up Arrangement, in exchange
for providing as well as not withdrawing a launch arrangement, Dr. Cost will certainly be qualified to
get from the Business (i) discontinuance wage in a quantity equivalent to $100,000,
payable in considerably equivalent installations according to the Business’s
pay-roll method over 3 months, starting on the very first pay-roll day after Dr. Cost’s launch of the Business ends up being efficient as well as irreversible as well as (ii) an
quantity equivalent to $100,000 as Dr. Cost’s yearly reward for 2022, payable on the
initially pay-roll day after Dr. Cost’s launch of the Business ends up being efficient
as well as irreversible.

The foregoing summary of the Splitting up Arrangement is certified in its
whole by recommendation to the total message of such arrangement, a duplicate of which is
affixed as Exhibition 10.1 to this Existing Record on Kind 8-K, as well as integrated
here by recommendation.

Visit of brand-new President, Head Of State, Principal Exec
Police Officer, Principal Financial Police Officer as well as Principal Accountancy Police Officer

On January 12, 2023, the Board selected Joseph Hooker as the Business’s Meantime
President, Head Of State, Principal Exec Police Officer, Principal
Financial Police Officer as well as Principal Accountancy Policeman, efficient since January 12,
2023.

Before signing up with NeuroBo, Mr. Hooker was an independent specialist as well as suggested
on an impromptu basis for leading administration working as a consultants as well as different
pharmaceutical business relative to scientific tests, CROs as well as program
administration. From Might 2019 via October 2020, Mr. Hooker was Sr. Supervisor of
Professional Operations/Program Leader Rare Illness, Oncology for X4
Drugs, Inc., where he led a crossfunctional international program group
pre-clinical via advancement as well as commercialization consisting of calculated
preparation, oversight, implementation of scientific procedures as well as the administration of
team. From March 2018 to March 2019, Mr. Hooker functioned as Supervisor, Program
Management at Biogen, where he led programs as well as scientific advancement for genetics
treatment, ALS, ophthalmology, uncommon orphan condition as well as CNS. From September 2017
via February 2018 he functioned as Elderly Supervisor, Professional Workflow at
Pierian Bioscience, where he developed, established as well as led scientific procedures for an
oncology gadget program. He additionally functioned as primary running police officer of
MedAvante-ProPhase from March 2017 to August 2017. Mr. Hooker functioned as Head,
Professional Workflow for Sandoz Biopharmaceuticals, department of Novartis, from
February 2014 to Might 2015. Mr. Hooker started his pharmaceutical job as Senior citizen
Professional Test Supervisor as well as task leader at DuPont-Merck Pharmaceuticals, as well as
additionally offered at different times in scientific test administration duties at County
Drugs, Cephalon Pharmaceuticals, Quintiles as well as Novo Nordisk. Mr.
Hooker obtained a bachelor’s degree from Rutgers College as well as an MBA from Cyclist College.

According to an interaction arrangement in between the Business as well as Korn Ferryboat, dated
January 12, 2023, Mr. Hooker will certainly get his payment as well as gain from
Korn Ferryboat. About the visit of Mr. Hooker as acting Principal
Exec Police Officer as well as Head Of State of the Business as well as the Business’s Principal
Exec Police Officer, Principal Financial Police Officer as well as Principal Accountancy Police Officer,
the Business anticipates to pay Korn Ferryboat roughly $16,000 each week under the
involvement arrangement.

On top of that, Mr. Hooker participated in a Proprietary Details as well as Development
Job Arrangement with the Business that uses throughout the regard to Mr.
Hooker’s solution as a police officer of the Business.

Other than as explained over, there are no setups or understandings in between Mr. Hooker as well as any kind of various other individuals according to which Mr. Hooker was called Meantime
President as well as Head Of State of the Business as well as the Business’s Principal
Exec Police Officer, Principal Financial Police Officer as well as Principal Accountancy Police Officer. Mr. Hooker does not have any kind of family members partnership with any one of the Business’s
supervisors or exec policemans or anybodies chosen or selected by the
Business to be a supervisor or executive police officer. Mr. Hooker does not have any kind of
straight or indirect product passion in any kind of purchase or recommended purchase
needed to be reported under Thing 404(a) of Guideline S-K.

Thing 7.01 Guideline FD Disclosure.

On January 18, 2023, the Business released a news release revealing the modifications
to the management group. A duplicate of journalism launch is affixed hereto as
Exhibition 99.1 as well as is integrated right into this Thing 7.01 by recommendation.

The details in Thing 7.01 of this Existing Record on Kind 8-K as well as Exhibition 99.1
affixed hereto is meant to be equipped as well as will not be regarded “submitted” for
functions of Area 18 of the Stocks Exchange Act of 1934, as changed
(the “Exchange Act”) or otherwise based on the responsibilities of that area,
neither will it be regarded integrated by recommendation in any kind of declaring under the
Stocks Act of 1933, as changed, or the Exchange Act, other than as specifically established
forth by particular recommendation in such declaring.

Thing 9.01 Financial Statements as well as Displays.

(d) Exhibits




Exhibition
 Number                               Exhibition Summary
  10.1       Splitting Up as well as Launch Arrangement participated in on January 16, 2023 by
           as well as in between NeuroBo Pharmaceuticals, Inc. as well as Gil Cost.
  99.1       News release provided by NeuroBo Pharmaceuticals, Inc. on January 18,
           2023
104        Cover Web Page Interactive Information Data (ingrained within Inline XBRL paper).

© Edgar Online, resource Peeks